You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (4)

Journals (0)

1-4 of 4 results for pan-HER inhibitor

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)

Open access

Research article

First published 2025

A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)

Bora Lim, Angela Marx, Megumi Kai [...]

Therapeutic Advances in Medical Oncology

Select article: Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers

Open access

Research article

First published 2018

Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers

Malgorzata Milewska, Mattia Cremona, Clare Morgan [...]

Therapeutic Advances in Medical Oncology

Select article: Frequency,impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer

Open access

Research article

First published 2018

Frequency,impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer

Naomi Elster, Sinead Toomey, Yue Fan [...]

Therapeutic Advances in Medical Oncology

Select article: Real-world data of triplet combination of pyrotinib,trastuzumab,and chemotherapy in HER2-positive metastatic breast cancer: a multicenter,retrospective study

Open access

Research article

First published 2023

Real-world data of triplet combination of pyrotinib,trastuzumab,and chemotherapy in HER2-positive metastatic breast cancer: a multicenter,retrospective study

Shuhui You, Die Sang, Fei Xu [...]

Therapeutic Advances in Medical Oncology

1
10 / page

Article type

Publication date

Subjects

Access